A Big Upgrade for Amylin Pharmaceuticals
Motley Fool
After Amylin Pharmaceuticals (Nasdaq: AMLN) held no better than a three-star ranking for most of the past year, enough top-performing CAPS members have

and more »

A Big Upgrade for Amylin Pharmaceuticals – Motley Fool

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

Random Posts

Related posts:

  1. Amylin Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
  2. A Big Upgrade for Teva Pharmaceutical – Motley Fool
  3. Cumberland Pharmaceuticals Inc. (CPIX) Chief Executive Officer AJ … – DMN Newswire (press release)